{"id":67187,"date":"2026-06-03T14:03:33","date_gmt":"2026-06-03T06:03:33","guid":{"rendered":"https:\/\/flcube.com\/?p=67187"},"modified":"2026-06-03T14:03:34","modified_gmt":"2026-06-03T06:03:34","slug":"xtalpis-ai-biology-spin-off-infevo-secures-tens-of-millions-in-angel-funding-to-build-virtual-cell-system-for-drug-discovery","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=67187","title":{"rendered":"Xtalpi&#8217;s AI Biology Spin-off INFevo Secures Tens of Millions in Angel Funding to Build Virtual Cell System for Drug Discovery"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Xtalpi Inc.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/2228:HKG\">HKG: 2228<\/a>) announced that its AI biology subsidiary <strong>INFevo<\/strong> has completed an <strong>angel financing round<\/strong>, raising <strong>tens of millions of renminbi<\/strong> from leading China-based venture capital firms including <strong>Shunwei Capital<\/strong>, <strong>HongShan<\/strong>, and <strong>Green Pine Capital Partners<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The funding will accelerate development of INFevo&#8217;s pioneering <strong>AI-powered &#8220;Virtual Cell System&#8221;<\/strong>, which aims to <strong>decode the fundamental language of life<\/strong> and provide transformative tools for <strong>innovative drug discovery<\/strong> and <strong>cell engineering design<\/strong> across multiple therapeutic areas including anti-aging, neurodegenerative diseases, and oncology.<\/p>\n\n\n\n<h2 id=\"h-investment-details-amp-strategic-backing\" class=\"wp-block-heading\">Investment Details &amp; Strategic Backing<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Parameter<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Parent Company<\/strong><\/td><td>Xtalpi Inc. (HKG: 2228)<\/td><\/tr><tr><td><strong>Subsidiary<\/strong><\/td><td>INFevo (AI biology company)<\/td><\/tr><tr><td><strong>Funding Round<\/strong><\/td><td>Angel financing<\/td><\/tr><tr><td><strong>Amount Raised<\/strong><\/td><td>Tens of millions RMB<\/td><\/tr><tr><td><strong>Lead Investors<\/strong><\/td><td>Shunwei Capital, HongShan, Green Pine Capital Partners<\/td><\/tr><tr><td><strong>Investment Focus<\/strong><\/td><td>AI-driven biomedical research platform development<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-core-technology-platform\" class=\"wp-block-heading\">Core Technology Platform<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Foundation Model<\/strong>: Proprietary state-of-the-art (SOTA) large language model <strong>OCOO<\/strong><\/li>\n\n\n\n<li><strong>Integration<\/strong>: Seamless combination with automated and intelligent cell experimentation platforms<\/li>\n\n\n\n<li><strong>Vision<\/strong>: World-leading AI-powered biomedical innovation research platform for the AI era<\/li>\n\n\n\n<li><strong>Unique Value Proposition<\/strong>: Bridges computational biology with wet-lab experimentation through closed-loop learning<\/li>\n\n\n\n<li><strong>Research Support<\/strong>: Designed to enable scientific breakthroughs in basic biology research<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-therapeutic-focus-areas\" class=\"wp-block-heading\">Therapeutic Focus Areas<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Disease Area<\/th><th>Research Applications<\/th><\/tr><\/thead><tbody><tr><td><strong>Anti-Aging<\/strong><\/td><td>Novel mechanism discovery, longevity target identification<\/td><\/tr><tr><td><strong>Neurodegenerative Diseases<\/strong><\/td><td>Target validation, virtual drug screening<\/td><\/tr><tr><td><strong>Autoimmune Diseases<\/strong><\/td><td>Pathway analysis, therapeutic intervention design<\/td><\/tr><tr><td><strong>Metabolic Disorders<\/strong><\/td><td>Metabolic network modeling, compound evaluation<\/td><\/tr><tr><td><strong>Oncology<\/strong><\/td><td>Cancer biology insights, combination therapy optimization<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-comprehensive-ai-biology-platform-capabilities\" class=\"wp-block-heading\">Comprehensive AI Biology Platform Capabilities<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Novel Mechanism &amp; Target Discovery<\/strong>: AI-driven identification of previously unknown biological pathways<\/li>\n\n\n\n<li><strong>Virtual Drug Screening &amp; Evaluation<\/strong>: In silico compound assessment with predictive accuracy<\/li>\n\n\n\n<li><strong>Clinical Protocol Optimization<\/strong>: AI-guided trial design and patient stratification<\/li>\n\n\n\n<li><strong>Translational Bridge<\/strong>: Direct connection between basic research discoveries and clinical applications<\/li>\n\n\n\n<li><strong>End-to-End Solution<\/strong>: Complete pipeline from target identification through clinical development support<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-strategic-implications-for-xtalpi\" class=\"wp-block-heading\">Strategic Implications for Xtalpi<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>AI Biology Leadership<\/strong>: Positions Xtalpi at forefront of AI-driven life sciences innovation<\/li>\n\n\n\n<li><strong>Platform Monetization<\/strong>: Multiple revenue streams through platform licensing and partnerships<\/li>\n\n\n\n<li><strong>Global Ambitions<\/strong>: Technology designed to serve international pharmaceutical and biotech companies<\/li>\n\n\n\n<li><strong>Competitive Moat<\/strong>: Integration of proprietary LLM with experimental platforms creates significant barriers to entry<\/li>\n\n\n\n<li><strong>Ecosystem Development<\/strong>: Potential to become foundational infrastructure for next-generation drug discovery<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-market-impact-analysis\" class=\"wp-block-heading\">Market Impact Analysis<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Paradigm Shift<\/strong>: Moves drug discovery from traditional trial-and-error approaches to AI-guided precision design<\/li>\n\n\n\n<li><strong>R&amp;D Efficiency<\/strong>: Potential to significantly reduce drug development timelines and costs<\/li>\n\n\n\n<li><strong>Innovation Acceleration<\/strong>: Enables exploration of previously intractable biological targets and mechanisms<\/li>\n\n\n\n<li><strong>Competitive Landscape<\/strong>: Enters growing field of AI biology companies but differentiated by integrated wet-dry lab approach<\/li>\n\n\n\n<li><strong>Global Relevance<\/strong>: Addresses universal challenges in pharmaceutical R&amp;D with scalable technology platform<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward-Looking Statements<\/strong><br>This brief contains forward-looking statements regarding technology development, platform capabilities, and market opportunities for INFevo. Actual results may differ due to technological challenges, competitive dynamics, and market adoption factors.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Xtalpi Inc. (HKG: 2228) announced that its AI biology subsidiary INFevo has completed an angel&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1],"tags":[1112,696],"class_list":["post-67187","post","type-post","status-publish","format-standard","hentry","category-uncategorized","tag-hkg-2228","tag-xtalpi"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Xtalpi&#039;s AI Biology Spin-off INFevo Secures Tens of Millions in Angel Funding to Build Virtual Cell System for Drug Discovery - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Xtalpi Inc. (HKG: 2228) announced that its AI biology subsidiary INFevo has completed an angel financing round, raising tens of millions of renminbi from leading China-based venture capital firms including Shunwei Capital, HongShan, and Green Pine Capital Partners.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=67187\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Xtalpi&#039;s AI Biology Spin-off INFevo Secures Tens of Millions in Angel Funding to Build Virtual Cell System for Drug Discovery\" \/>\n<meta property=\"og:description\" content=\"Xtalpi Inc. (HKG: 2228) announced that its AI biology subsidiary INFevo has completed an angel financing round, raising tens of millions of renminbi from leading China-based venture capital firms including Shunwei Capital, HongShan, and Green Pine Capital Partners.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=67187\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-03T06:03:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-03T06:03:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67187#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67187\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Xtalpi&#8217;s AI Biology Spin-off INFevo Secures Tens of Millions in Angel Funding to Build Virtual Cell System for Drug Discovery\",\"datePublished\":\"2026-06-03T06:03:33+00:00\",\"dateModified\":\"2026-06-03T06:03:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67187\"},\"wordCount\":470,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"HKG: 2228\",\"Xtalpi\"],\"articleSection\":[\"Others\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=67187#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67187\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=67187\",\"name\":\"Xtalpi's AI Biology Spin-off INFevo Secures Tens of Millions in Angel Funding to Build Virtual Cell System for Drug Discovery - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-06-03T06:03:33+00:00\",\"dateModified\":\"2026-06-03T06:03:34+00:00\",\"description\":\"Xtalpi Inc. (HKG: 2228) announced that its AI biology subsidiary INFevo has completed an angel financing round, raising tens of millions of renminbi from leading China-based venture capital firms including Shunwei Capital, HongShan, and Green Pine Capital Partners.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67187#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=67187\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67187#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Xtalpi&#8217;s AI Biology Spin-off INFevo Secures Tens of Millions in Angel Funding to Build Virtual Cell System for Drug Discovery\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Xtalpi's AI Biology Spin-off INFevo Secures Tens of Millions in Angel Funding to Build Virtual Cell System for Drug Discovery - Insight, China&#039;s Pharmaceutical Industry","description":"Xtalpi Inc. (HKG: 2228) announced that its AI biology subsidiary INFevo has completed an angel financing round, raising tens of millions of renminbi from leading China-based venture capital firms including Shunwei Capital, HongShan, and Green Pine Capital Partners.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=67187","og_locale":"en_US","og_type":"article","og_title":"Xtalpi's AI Biology Spin-off INFevo Secures Tens of Millions in Angel Funding to Build Virtual Cell System for Drug Discovery","og_description":"Xtalpi Inc. (HKG: 2228) announced that its AI biology subsidiary INFevo has completed an angel financing round, raising tens of millions of renminbi from leading China-based venture capital firms including Shunwei Capital, HongShan, and Green Pine Capital Partners.","og_url":"https:\/\/flcube.com\/?p=67187","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-06-03T06:03:33+00:00","article_modified_time":"2026-06-03T06:03:34+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=67187#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=67187"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Xtalpi&#8217;s AI Biology Spin-off INFevo Secures Tens of Millions in Angel Funding to Build Virtual Cell System for Drug Discovery","datePublished":"2026-06-03T06:03:33+00:00","dateModified":"2026-06-03T06:03:34+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=67187"},"wordCount":470,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["HKG: 2228","Xtalpi"],"articleSection":["Others"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=67187#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=67187","url":"https:\/\/flcube.com\/?p=67187","name":"Xtalpi's AI Biology Spin-off INFevo Secures Tens of Millions in Angel Funding to Build Virtual Cell System for Drug Discovery - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-06-03T06:03:33+00:00","dateModified":"2026-06-03T06:03:34+00:00","description":"Xtalpi Inc. (HKG: 2228) announced that its AI biology subsidiary INFevo has completed an angel financing round, raising tens of millions of renminbi from leading China-based venture capital firms including Shunwei Capital, HongShan, and Green Pine Capital Partners.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=67187#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=67187"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=67187#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Xtalpi&#8217;s AI Biology Spin-off INFevo Secures Tens of Millions in Angel Funding to Build Virtual Cell System for Drug Discovery"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/67187","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=67187"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/67187\/revisions"}],"predecessor-version":[{"id":67188,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/67187\/revisions\/67188"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=67187"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=67187"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=67187"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}